Taking Your Meds? A Digital Pill Can Tell
Taking Your Meds? A Digital Pill Can Tell

Taking Your Meds? A Digital Pill Can Tell

Digital pills may help health care providers track whether you're taking your medicine as prescribed.

Your Care

HealthDay News


MONDAY, Dec. 4, 2017 (HealthDay News)—Pairing medication with an ingestible sensor can help clinicians track how often and when patients actually take their prescription drugs, according to a small new investigational study.

The findings come on the heels of the U.S. Food and Drug Administration's decision last month to approve the first digital pill for use with the antipsychotic drug Abilify, often prescribed to treat schizophrenia, bipolar disorder and depression.

The new research involved just 15 patients, all of whom had been prescribed the opioid pain drug oxycodone (OxyContin) after sustaining a fracture.

However, the study participants were given a special configuration of oxycodone. The pain med was packaged together with a so-called "digital pill." This meant that each time a patient took the pain med, they ingested a gelatin capsule that contained the oxycodone as well as a radiofrequency emitter.

The emitter was automatically activated when the capsule was swallowed. It sent signals to a sticky patch placed on the person's abdomen. That, in turn, conveyed basic pill-taking information to an iPod-sized reader.

The system enabled researchers to track how many pills the 15 patients took, rather than the number of pills they'd been given.

On average, the patients took just six pills total—even though they had been provided a supply of 21 pills, according to the report.

"As an investigational tool, the digital pill provides a direct measure of opioid ingestion and changes in medication-taking behavior," senior author Dr. Edward Boyer said in a news release from Brigham and Women's Hospital in Boston.

"This technology may also make it possible for physicians to monitor adherence, identify escalating opioid use patterns that may suggest the development of tolerance or addiction, and intervene for a specific medical condition or patient population," he added.

Boyer is with the medical toxicology division within the hospital's department of emergency medicine.

Boyer and his colleagues published their findings in the December issue of the journal Anesthesia & Analgesia.

SOURCE: Brigham and Women's Hospital, news release, Nov. 20, 2017

Copyright © 2017 HealthDay. All rights reserved.

ADVERTISEMENT

Qué hacer después de ser diagnosticada con la enfermedad de Alzheimer de inicio precoz

El Alzheimer de inicio temprano afecta a personas en las edades de 30, 40, 50 y al principio de los 60 - Aprenda a reconocer las señales.

Created With Support

Suffering in Silence: Middle-Aged Women and Eating Disorders

Shedding light on a condition that's more common than you think

Self-Care & Mental Health

Inquietudes Comunes Acerca de las Vacunas

Lo que preocupa a muchas personas acerca de las vacunas - y la información que pudiera darles seguridad y confianza

Created With Support